Robert Marshall
Director of Finance/CFO chez LANTHEUS HOLDINGS, INC.
Fortune : 7 M $ au 31/03/2024
Profil
Robert J.
Marshall is currently the Chief Financial Officer & Treasurer at Lantheus Holdings, Inc. Prior to his current position, he served as the Chief Financial Officer & Treasurer at Progenics Pharmaceuticals, Inc. He also held the position of Treasurer at Zimmer Biomet Holdings, Inc. from 2018 to 2019.
Additionally, he worked as the Treasurer & Vice President-Investor Relations at Zimmer, Inc. Mr. Marshall completed his undergraduate degree at the University of Notre Dame and holds an MBA from Indiana University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
LANTHEUS HOLDINGS INC
0,17% | 15/03/2024 | 113 749 ( 0,17% ) | 7 M $ | 31/03/2024 |
Postes actifs de Robert Marshall
Sociétés | Poste | Début |
---|---|---|
LANTHEUS HOLDINGS, INC. | Director of Finance/CFO | 21/09/2018 |
Anciens postes connus de Robert Marshall
Sociétés | Poste | Fin |
---|---|---|
ZIMMER BIOMET HOLDINGS, INC. | Investor Relations Contact | 19/03/2018 |
PROGENICS PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Zimmer, Inc.
Zimmer, Inc. Medical SpecialtiesHealth Technology Zimmer, Inc. provides joint replacement solutions. The firm products include trauma and dental implants and orthopaedic surgical products. The company was founded in 1927 and is headquartered in Warsaw, IN. | Investor Relations Contact | - |
Formation de Robert Marshall
University of Notre Dame | Undergraduate Degree |
Indiana University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ZIMMER BIOMET HOLDINGS, INC. | Health Technology |
LANTHEUS HOLDINGS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Zimmer, Inc.
Zimmer, Inc. Medical SpecialtiesHealth Technology Zimmer, Inc. provides joint replacement solutions. The firm products include trauma and dental implants and orthopaedic surgical products. The company was founded in 1927 and is headquartered in Warsaw, IN. | Health Technology |